ERBB2 and breast cancer: Next, multivariate analysis was performed to evaluate the implication of parameters including depth of invasion (T3 ~ T4), lymph node metastasis (N2 ~ N3), TNM stage (III ~ IV), PR negativity and HER-2 negativity on breast cancer prognosis (Table 6 right).